The monitors - which Pharmac is now funding for all type 1 diabetics - mean patients are less likely to suffer early deaths, ...

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Ascensia Diabetes Care, a global diabetes care company, announces that it is launching the Eversense® 365 continuous glucose monitoring (CGM) system, the world's only One Year CGM, to people with ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

RBC Capital initiated coverage of Tandem Diabetes Care (NASDAQ:TNDM) with an Outperform rating in a note Wednesday, highlighting the stock’s attractive risk-reward profile.

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor ... for type 1 and type 2 diabetes, respectively, the G7 and Libre 3 range.

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...

The Global Burden of Disease reported that in 2017, 1.2 million people died from chronic kidney ... Key product approvals ...

Recommended The best diet to prevent Type 2 diabetes Read more Dr David Cavan ... Dr Cavan recommends using a blood glucose monitor such as the Freestyle Libre to see exactly how your body responds to ...

Recommended The best diet to prevent Type 2 diabetes Read more Dr David Cavan ... Dr Cavan recommends using a blood glucose monitor such as the Freestyle Libre to see exactly how your body responds to ...